Changing Practices in COPD

This publication has 16 references indexed in Scilit:

• Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1
  JAMA, 1994
• In Chronic Obstructive Pulmonary Disease, a Combination of Ipratropium and Albuterol Is More Effective Than Either Agent Alone
  Chest, 1994
• Slowing the Deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed during Bronchodilator Therapy by Adding Inhaled Corticosteroids: A 4-Year Prospective Study
  Annals of Internal Medicine, 1993
• Management of Chronic Obstructive Pulmonary Disease
  New England Journal of Medicine, 1993
• Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.
  BMJ, 1991
• Regular inhaled beta-agonist treatment in bronchial asthma
  The Lancet, 1990
• The Course and Prognosis of Different Forms of Chronic Airways Obstruction in a Sample from the General Population
  New England Journal of Medicine, 1987
• Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center study
  The American Journal of Medicine, 1986
• A Comparison of the Bronchodilating Effects of a Beta-2 Adrenergic Agent (Albuterol) and an Anticholinergic Agent (Ipratropium Bromide), Given by Aerosol Alone or in Sequence
  New England Journal of Medicine, 1986
• Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema.
  Thorax, 1982